Take Solutions Limited has launched an Innovation Fund with an initial corpus of Rs. 50 million to invest in startups converging AI, deep technology and the health and wellness sector. The fund will target early and growth stage companies that leverage data, artificial intelligence and scientific innovation to transform diagnostics, delivery and health outcomes. The company said the move represents a strategic pivot towards next generation technology led business models and long term shareholder value creation.

The Innovation Fund will provide capital and strategic support including domain expertise, global networks and go to market access to accelerate commercialisation and scalability. The fund will prioritise investments in AI led diagnostics, longevity and bio convergence, digital health platforms and technology infrastructure that enhance efficiency and compliance. The approach is designed to reduce time to market and increase the probability of success for portfolio companies by combining capital with operational capabilities.

The company highlighted India's expanding health and wellness market projected to grow to $400 to $500 billion over the next decade, driven by rising digital adoption, healthcare awareness and increasing life expectancy. It noted chronic diseases account for nearly 60 per cent of deaths and that extending healthspan creates opportunities in predictive analytics, precision medicine and digital therapeutics. Take.Health, an AI driven platform recently launched by the company, aims to convert everyday lifestyle and medical data into personalised actionable insights for consumer and enterprise segments.

The investment thesis is anchored in the convergence of biology and technology and seeks long term, high impact outcomes while generating sustainable financial returns. The fund will leverage the company's expertise in life sciences and supply chain management, institutional partnerships across clinical and regulatory networks, and established go to market channels to support portfolio commercialisation. With disciplined deployment and execution capabilities, the company expects the initiative to strengthen its position in innovation led sectors and participate in the evolving technology driven economy.